Dr. Jeremy Bridge-Cook is currently Chief Scientific Officer and VP R&D at Genomadix Inc., a point of care PCR diagnostics company. Prior to this, Jeremy was President and CEO of Rna Diagnostics, a personalized cancer diagnostics company specializing in monitoring cancer therapy efficacy, where he raised $13 million in several financing rounds.
Prior to this, he worked at Luminex Corporation and Tm Bioscience (TMB, acquired by Luminex in 2007) for 16 years in positions of increasing responsibility. Jeremy was VP of Business Development, VP Sales & Marketing and Senior VP Corporate Development at TMB, and subsequently served as Senior VP of Research & Development at Luminex Corp.
Prior to working at Luminex/TMB, Jeremy worked as an Investment Manager at MDS Capital Corp., a venture capital company focused on Life Science investments. Jeremy received his B.Sc. from McMaster University and Ph.D. of Immunology from the University of Toronto.